EARLY Aggressive Treatment

"Treat first. Test later. Don't wait for test results."
"Delay is what's killing people."
- Dr. Darrell DeMello, MD


Despite the constant 'get vaccinated' drumbeat, Americans are still getting Covid-19, even the vaccinated. The above graph was provided by U.S. Senator Ron Johnson in his December 8, 2020 committee hearing on early treatment for Covid-19. It shows three stages of infection. It’s important to stop the viral replication stage, thereby avoiding the dangerous cytokine storm and the microthrombosis (mini-clots) stages. Options for receiving early treatment, including ivermectin or hydroxychloroquine (HCQ), can be found here if an individual cannot find access to early treatment elsewhere:

NOTE: THIS IS NOT MEDICAL ADVICE. LISTS AND LINKS ARE FROM OUTSIDE SOURCES AND NOT GUARANTEED TO BE ACCURATE OR UP-TO-DATE. ALWAYS CONSULT A MEDICAL PROFESSIONAL BEFORE BEGINNING TREATMENT. BY USING THIS WEBSITE OR INFORMATION, YOU AGREE TO THESE AND ADDITIONAL TERMS WRITTEN BELOW. 

____________

COVID-19 Quick Reference Guide

Click here for complete pdf to print/download (bit.ly/CCHFguide)

Lists of Physicians (in alpha order-expect duplicates):

Disclaimer: As more Americans contact these physicians, waiting times have dramatically increased. Individuals may want to contact more than one physician to secure timely access to medications for treatment or prophylaxis.

Also:

​Pharmacies:

Physician-Created Guidelines and Protocols:

DIY Early Treatment Kit

Use this list to create your own Early Treatment Kit at home for yourself and your family. Most of these items can be found over-the-counter at your local drugstore or pharmacy. Click here for a printable pdf.

Additional items to add include: pulse oximeter with extra set of batteries, several Covid home test kits, iodine nasal spray or 10% povidone-iodine solution for dilution to create nose drops, hydrogen peroxide, nebulizer, thermometer, aspirin 325 mg, Pepcid, sufficient D3 to take 30,000 - 50,000 IU for several days to start, and spreadsheet for tracking completed doses of medication and suppliments—and the COVID-19 Quick Reference Guide.

 

 

Transcript

PARTIAL TRANSCRIPT

Dr. Tina Peers from UK Discusses the Management of Long Haul Syndrome [And Mast Cell Activation Syndrome]

May 21, 2021

Drbeen Medical Lectures

https://www.youtube.com/watch?v=NOkUDh3vHVU&list=PLqFVU9Pg5lSHq3GVIsnkguTXWEugKx-t7&index=3

Notes and partial transcription by Twila Brase, President and Co-founder, CCHF, Feb 12, 2022

 

 

 

PARTIAL TRANSCRIPT

Darrell DeMello Discusses COVID Outpatient Management

[STAGES / COVID TYPES / TREATMENT EMPHASIS]

September 2, 2021

MoBeen Medical Lectures

https://www.youtube.com/watch?v=k6_ICQYjNGc&list=PLqFVU9Pg5lSHq3GVIsnkguTXWEugKx-t7&index=6

Notes and transcription by Twila Brase, CCHF, Feb 12, 2022

 

PARTIAL TRANSCRIPT

Dr. Darrell DeMello Discusses Covid Outpatient Management

[COLCHICINE FOCUS | PPT SLIDES]

Sept 17, 2021

Mobeen Medical Lectures

https://www.youtube.com/watch?v=43pOPZx-LQY

Notes and transcription by Twila Brase, CCHF, Feb 12, 2022

 

Interviews With COVID-19 Treating Physicians:

IMPORTANT IVERMECTIN STUDIES

"Review of Emerging Evidence Demonstrating the Efficacy of Ivermection in the Prophylaxis and Treatment of COVID-19"  Pierre Kory, MD, et al, American Journal of Therapeutics, May/June 2021

"In summary, based on the totality of the trials and epidemiologic evid3nce presented in theis review along with the preliminary findings of the Unitaid/WHO meta-analysis of treatment RCTs and the guideline recommendation from the international BIRD conference, ivermectin should be globally and systematically deployed in the prevention and treatment of COVID-19." [emphasis ours]

 

"Favorable outcome on viral load and culture viability using Ivermectin in early treatment of non-hositalizaed patients with mild COVID-19 -- a double-blind. randomized placebo-controlled trial," Asa Biber, et al, medRxiv preprint, May 31, 2021

"[T]he odds of a negative test at day 6 was 2.62 times higher in the ivermectin group...Cultures at days 2 to 6 were positive in 3/23 (13.0%) of ivermectin samples vs. 14/29 (48.2%) in the placebo group..."

"One may wonder about the public health benefit of treating mild patients since shortening the period of relatively mild symptoms may not merit a mass drug administration of ivermectin to the large population of non-hospitalized patients. However, inducing faster viral clearance and therefore reducing the time until the patient reaches a state of being non-infectious have an extremely important public health impact. Taking the two composites; Ct values above 30 and negative cultures, leads to almost 90% non-infectious status at day four (one day after ending treatment) among ivermectin users. From the public health point of view, it may shorten isolation time, which can serve as a major relief of the economic and social burden." [emphasis ours]

 

LONG HAUL COVID

In his June 24, 2021 interview on DrBeen Medical Lectures, Dr. Bruce Patterson, MD, co-founder of the Chronic COVID Treatment Center (which has a network of 100 physicians nationwide), says patients with "Long Covid" are not only those who were infected with Covid, but the vaccinated who have never had Covid—due to the Covid spike protein: "Spike Proteins In Immune Cells - Dr. Bruce Patterson Discusses COVID Long Haul." Dr. Mobeen restating an earlier guest said, "Long haul does not occur if you're treating with ivermectin" (21:00 mark)

 

LIMITATION OF LIABILITY
This information is provided as a not-for-profit public service by people who are not medical professionals and have no professional relationship with you for diagnostic or treatment purposes. In no event shall Citizens' Council for Health Freedom or any staff, directors, or officers of CCHF be liable for any special, incidental or consequential damages or injury arising out of or in connection with this information or website, including negligence. Use the information and resources at your own risk and with your own discretion, and always with the advice of a medical professional of your own choice.

​BY USING THIS WEBSITE OR INFORMATION, YOU AGREE TO THESE TERMS.

 


a project of